J&J Innovation taps Texas for its latest biotech startup incubator

Tracy Staton Johnson & Johnson taking its network of biopharma incubators to Texas in an expansion of its Janssen Labs initiative. FiercePharma News

J&J Innovation settles into a fast-paced global swirl of dealmaking

John Carroll Over the last 6 months or so, Johnson & Johnson's ($ JNJ) big new innovation initiative has been bringing together deal teams in key R&D hot spots around the ...

J&J innovation team sets up international collaboration to discover Alzheimer’s drugs

John Carroll J&J has spent hundreds of millions of dollars in a so-far failed effort to develop a late-stage biologic that could be used to treat Alzheimer's. And it's now ...

Merck Serono’s new HQ taps open-office style to encourage innovation

Tracy Staton The redesigned buildings on Merck KGaA's campus feature the sort of flexible work stations and open-office arrangements recently adopted by GlaxoSmithKline in Philadelphia ...

Global Health Innovation Fund Buys Physicians Interactive

barbara.lempert Perseus Partners VII Sells Physicians Interactive Physicians Interactive Holdings Inc. Board of Directors Approves Transaction WASHINGTON, DC–(Marketwired ...

In pharma, incremental innovation lives on

Alok Saboo Payers have become increasingly unwilling to pay for incremental drug innovation, meaning that the industry would have to instead seek bigger improvements in clinical performance. ...

Regeneron Announces First Recipients of Annual Regeneron Prize for Creative Innovation

barbara.lempert New National Prize Recognizes Talented Early-Career Scientists Poised to Make Important Contributions to Scientific Discovery TARRYTOWN, N.Y., June 27, 2013 /PRNewswire/ ...

J&J backs two biotech startups, inaugurates innovation center

Tracy Staton The Cambridge, MA, center is one of four planned by J&J. FiercePharma News

J&J’s pharma chairman lands ‘more deals’ in Boston innovation push

Ryan McBride FierceBiotech News

Analysis: Big Pharma R&D demonstrates a woeful lack of innovation

John Carroll Bernard Munos, one of the sharpest critics of the drug development industry, takes Big Pharma to task once again on the innovation front after reviewing just what's ...

Macrocyclics to Collaborate with Roche on Molecular Innovation for Nuclear Medicine

barbara.lempert DALLAS, May 23, 2013 /CNW/ – After the successful completion of their first 2012 collaboration, Macrocyclics (an AREVA Med company) announced today a new collaborative ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS